tert-Butyl (3-(3-bromophenyl)oxetan-3-yl)carbamate
- $440 - $1856
- Product name: tert-Butyl (3-(3-bromophenyl)oxetan-3-yl)carbamate
- CAS: 1416323-32-4
- MF: C14H18BrNO3
- MW: 328.2
- EINECS:
- MDL Number:MFCD22628719
- Synonyms:tert-Butyl (3-(3-bromophenyl)oxetan-3-yl)carbamate;tert-butyl N-[3-(3-bromophenyl)oxetan-3-yl]carbamate;Carbamic acid, N-[3-(3-bromophenyl)-3-oxetanyl]-, 1,1-dimethylethyl ester
4 prices
Selected condition:
Brand
- Aaron Chemicals
- Chemenu
Package
- 100mg
- 250mg
- 1g
- ManufacturerAaron Chemicals
- Product numberAR01JTO7
- Product description3-Boc-amino-3-(3-bromophenyl)oxetane 97%
- Packaging100mg
- Price$440
- Updated2021-12-16
- Buy
- ManufacturerAaron Chemicals
- Product numberAR01JTO7
- Product description3-Boc-amino-3-(3-bromophenyl)oxetane 97%
- Packaging250mg
- Price$657
- Updated2021-12-16
- Buy
- ManufacturerAaron Chemicals
- Product numberAR01JTO7
- Product description3-Boc-amino-3-(3-bromophenyl)oxetane 97%
- Packaging1g
- Price$1091
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM291862
- Product descriptiontert-Butyl(3-(3-bromophenyl)oxetan-3-yl)carbamate 95+%
- Packaging1g
- Price$1856
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Aaron Chemicals | AR01JTO7 | 3-Boc-amino-3-(3-bromophenyl)oxetane 97% | 100mg | $440 | 2021-12-16 | Buy |
Aaron Chemicals | AR01JTO7 | 3-Boc-amino-3-(3-bromophenyl)oxetane 97% | 250mg | $657 | 2021-12-16 | Buy |
Aaron Chemicals | AR01JTO7 | 3-Boc-amino-3-(3-bromophenyl)oxetane 97% | 1g | $1091 | 2021-12-16 | Buy |
Chemenu | CM291862 | tert-Butyl(3-(3-bromophenyl)oxetan-3-yl)carbamate 95+% | 1g | $1856 | 2021-12-16 | Buy |
Properties
Boiling point :422.7±45.0 °C(Predicted)
Density :1.40±0.1 g/cm3(Predicted)
pka :10.71±0.20(Predicted)
Density :1.40±0.1 g/cm3(Predicted)
pka :10.71±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|